Agilent Technologies Inc
Chiusa
SettoreSettore sanitario
126.3 -0.71
Panoramica
Variazione del prezzo dell'azione
24h
Minimo
125.5
Massimo
127.37
Entrata | 34M 339M |
|---|---|
Vendite | 37M 1.8B |
P/E Media del settore | 26.223 49.712 |
EPS | 1.49 |
Rendimento da dividendi | 0.77 |
Margine di Profitto | 18.474 |
Dipendenti | 18,000 |
EBITDA | 44M 500M |
Raccomandazioni | Fortemente da comprare |
|---|---|
Previsioni per 12 mesi | +21.93% upside |
Rendimento da dividendi Media del settore | 0.77% 2.36% |
|---|---|
Utili prossimi | 26 ago 2026 |
Prossima data del Dividendo | 22 lug 2026 |
Prossima data del' Ex Dividendo | 30 giu 2026 |
Capitalizzazione di Mercato | 4.4B 37B |
|---|---|
Apertura precedente | 127.01 |
Chiusura precedente | 126.3 |
Notizie sul Sentiment di mercato
By Acuity
34%
66%
72 / 342 Classifica in Healthcare
Agilent Technologies Inc Grafico
Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.
Chi Siamo Agilent Technologies Inc
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.